Zobrazeno 1 - 5
of 5
pro vyhledávání: '"César V. Elizondo-Solis"'
Autor:
Sandra Castillo-Guzman, Omar González-Santiago, Ismael A. Delgado-Leal, Gerardo E. Lozano-Luévano, Misael J. Reyes-Rodríguez, César V. Elizondo-Solis, Teresa A. Nava-Obregón, Dionicio Palacios-Ríos
Publikováno v:
PeerJ, Vol 4, p e2255 (2016)
Background. Medications are not exempt from adverse drug reactions (ADR) and how the physician perceives the risk of prescription drugs could influence their availability to report ADR and their prescription behavior. Methods. We assess the perceptio
Externí odkaz:
https://doaj.org/article/1ac7e163376944dd8b6dc0a52ca9d32f
Autor:
Ernesto Torres-López, Leendert A. Trouw, Jesus Alberto Cardenas-de la Garza, Brenda Roxana Vázquez-Fuentes, Martha M Castañeda-Martinez, Salvador A Loredo-Alanis, Mario C. Salinas-Carmona, Miryam Eguia-Bernal, Gerardo E Rodriguez-Sanchez, César V. Elizondo-Solis, Andres Mendiola-Jimenez, P. Herrera-Sandate, Mario Alberto Garza-Elizondo, Diana D Castañeda-Martinez, Karina I Gonzalez-Torres, David Vega-Morales, D. Á. Galarza-Delgado, T. S. Gracia-Arechiga
Publikováno v:
Modern Rheumatology. TAYLOR & FRANCIS LTD
Modern Rheumatology
Modern Rheumatology
Objectives We aimed to determine the prevalence of anti-carbamylated protein (anti-CarP) antibodies in Mexican Hispanics with established rheumatoid arthritis (RA) and to assess their relationship with disease activity. Methods A cohort study was con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2980aae1a42a2ea48390a0af3d2fc5b
https://pubmed.ncbi.nlm.nih.gov/33853472
https://pubmed.ncbi.nlm.nih.gov/33853472
Autor:
Rodolfo Uriarte-Botello, D. Á. Galarza-Delgado, Griselda Serna-Peña, César V. Elizondo-Solis, Mario Alberto Garza-Elizondo, Miguel Ángel Villarreal-Alarcón, R. Pineda-Sic, L. Santoyo-Fexas, Ana Sofía Leal-Bramasco, Octavio Ilizaliturri-Guerra
Publikováno v:
Rheumatology international. 40(10)
Systemic lupus erythematosus (SLE) is an autoimmune disease, characterized by multi-organ symptomatology. 16% of the patients with autoimmune thrombocytopenia have SLE and are associated with high mortality. Intravenous methylprednisolone or high-dos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfc666e91c20c28e56c68ac587a792fd
https://pubmed.ncbi.nlm.nih.gov/32797277
https://pubmed.ncbi.nlm.nih.gov/32797277
Autor:
César V. Elizondo-Solis, Omar González-Santiago, Ismael A. Delgado-Leal, Sandra Castillo-Guzmán, Misael J. Reyes-Rodríguez, Teresa A. Nava-Obregón, Gerardo E. Lozano-Luévano, Dionicio Palacios-Ríos
Publikováno v:
PeerJ, Vol 4, p e2255 (2016)
PeerJ
PeerJ
Background. Medications are not exempt from adverse drug reactions (ADR) and how the physician perceives the risk of prescription drugs could influence their availability to report ADR and their prescription behavior. Methods. We assess the perceptio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cdd587c29a72a7fa985f070797db2a8
https://peerj.com/articles/2255/
https://peerj.com/articles/2255/
Publikováno v:
Medicina Universitaria, Vol 23, Iss 4 (2021)
Externí odkaz:
https://doaj.org/article/b81edc697640447e8c15d5ad2cb52070